Stock FLGT FULGENT GENETICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Fulgent Genetics, Inc.

Equities

FLGT

US3596641098

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-22 pm EDT 		5-day change 1st Jan Change
20.56 USD +0.98% Intraday chart for Fulgent Genetics, Inc. -0.92% -28.88%
Mar. 06 Piper Sandler Adjusts Price Target on Fulgent Genetics to $25 From $28, Maintains Neutral Rating MT
Feb. 29 UBS Adjusts Fulgent Genetics Price Target to $25 From $35, Maintains Neutral Rating MT

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Fulgent Genetics to Announce First Quarter 2024 Financial Results on Friday, May 3, 2024
BU
Piper Sandler Adjusts Price Target on Fulgent Genetics to $25 From $28, Maintains Neutral Rating
MT
UBS Adjusts Fulgent Genetics Price Target to $25 From $35, Maintains Neutral Rating
MT
Tranche Update on Fulgent Genetics, Inc.'s Equity Buyback Plan announced on March 8, 2022.
CI
Fulgent Genetics, Inc. Provides Earnings Guidance for the Year 2024
CI
Transcript : Fulgent Genetics, Inc., Q4 2023 Earnings Call, Feb 28, 2024
Fulgent Genetics, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023
CI
Fulgent Reports Fourth Quarter and Full Year 2023 Financial Results
BU
Earnings Flash (FLGT) FULGENT GENETICS Reports Q4 Revenue $70.5M
MT
Earnings Flash (FLGT) FULGENT GENETICS Reports Q4 EPS $0.28
MT
Fulgent Genetics to Announce Fourth Quarter and Full Year 2023 Financial Results on Wednesday, February 28, 2024
BU
Cooper Unit, Fulgent Genetic to Offer Newborn Genetic Screening Panels
MT
Cord Blood Registry® (CBR®) by CooperSurgical® and Fulgent Genetics Launch Innovative Genetic Testing
PR
Cord Blood Registry by CooperSurgical, Inc. and Fulgent Genetics, Inc. Launch Innovative Genetic Testing
CI
UBS Initiates Coverage on Fulgent Genetics With Neutral Rating, $35 Price Target
MT
Fulgent to Participate in the Piper Sandler 35th Annual Healthcare Conference
BU
Fulgent Shares Data from Two Poster Presentations at SITC 2023 Annual Meeting
BU
Fulgent Genetics, Inc. Announces Two Poster Presentations At SITC 2023 Annual Meeting
CI
Transcript : Fulgent Genetics, Inc., Q3 2023 Earnings Call, Nov 03, 2023
Tranche Update on Fulgent Genetics, Inc.'s Equity Buyback Plan announced on March 8, 2022.
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. FLGT Stock
  4. News Fulgent Genetics, Inc.